Researchers have found that with increasing popularity of GLP-1 drugs, their consumption has significantly increased among those with no FDA approved indications
A single capsule altering the gut microbiome via faecal microbiota transplantation (FMT) showed long-lasting metabolic improvements—potentially reducing diabetes and heart disease risk for years.